COMBINATION CISPLATIN, 5-FLUOROURACIL AND RADIATION THERAPY FOR LOCALLY ADVANCED UNRESECTABLE OR MEDICALLY UNFIT BLADDER CANCER CASES: A SOUTHWEST ONCOLOGY GROUP STUDY

Author:

HUSSAIN MAHA H.A.1,GLASS TRACY R.1,FORMAN JEFFREY1,SAKR WAEL1,SMITH DAVID C.1,AL-SARRAF MUHYI1,JONES JEFFREY1,BALCERZAK STANLEY P.1,CRAWFORD E. DAVID1,GROSSMAN H. BARTON1

Affiliation:

1. From Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, University of Michigan, Ann Arbor and Providence Hospital, Southfield, Michigan, Southwest Oncology Group Statistical Center, Seattle, Washington, Texas Tech University, Lubbock, Baylor College of Medicine and The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, Ohio State University, Columbus, Ohio, and University of Colorado, Denver, Colorado

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer of the bladder;Scher,1997

2. Radiotherapy for stage T3b transitional cell carcinoma of the bladder;Pollack;Semin Urol Oncol,1996

3. Staging and prognosis of T3b bladder cancer;Levy;Semin Urol Oncol,1996

4. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer;J Clin Oncol,,1992

5. Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder;Jakse;Cancer,1985

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3